New Key Statistics Module, Z-Score and F-Score
OTCPK:SHEZF Key Ratios
| Market Cap $ M | 2,095.61 |
| Enterprise Value $ M | 2,267.03 |
| P/E(ttm) | -- |
| PE Ratio without NRI | 21.60 |
| Forward PE Ratio | 6.02 |
| Price/Book | 1.37 |
| Price/Sales | 3.06 |
| Price/Free Cash Flow | 7.88 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 760.00 |
| EPS (TTM) $ | -0.01 |
| Beneish M-Score | -3.11 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -114.70 |
| EV-to-EBIT | -268.00 |
| EV-to-EBITDA | -268.00 |
| PEG | -- |
| Shares Outstanding M | 1,467.30 |
| Net Margin (%) | -2.68 |
| Operating Margin % | 14.30 |
| Pre-tax Margin (%) | -4.08 |
| Quick Ratio | 1.10 |
| Current Ratio | 2.39 |
| ROA % (ttm) | -0.77 |
| ROE % (ttm) | -1.21 |
| ROIC % (ttm) | 3.76 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.54 |
SHEZF Number of Guru Trades
SHEZF Volume of Guru Trades
Gurus Latest Trades with OTCPK:SHEZF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:SHEZF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Shenzhen Hepalink Pharmaceutical Group Co Ltd Insider Transactions
No Available Data
News about OTCPK:SHEZF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers